1. Home
  2. FCBC vs MDXG Comparison

FCBC vs MDXG Comparison

Compare FCBC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCBC
  • MDXG
  • Stock Information
  • Founded
  • FCBC 1874
  • MDXG 2006
  • Country
  • FCBC United States
  • MDXG United States
  • Employees
  • FCBC N/A
  • MDXG N/A
  • Industry
  • FCBC Major Banks
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCBC Finance
  • MDXG Health Care
  • Exchange
  • FCBC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • FCBC 737.6M
  • MDXG 877.4M
  • IPO Year
  • FCBC 1992
  • MDXG N/A
  • Fundamental
  • Price
  • FCBC $36.05
  • MDXG $7.11
  • Analyst Decision
  • FCBC
  • MDXG Buy
  • Analyst Count
  • FCBC 0
  • MDXG 1
  • Target Price
  • FCBC N/A
  • MDXG $12.00
  • AVG Volume (30 Days)
  • FCBC 40.3K
  • MDXG 855.6K
  • Earning Date
  • FCBC 07-22-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • FCBC 3.44%
  • MDXG N/A
  • EPS Growth
  • FCBC N/A
  • MDXG N/A
  • EPS
  • FCBC 2.72
  • MDXG 0.21
  • Revenue
  • FCBC $162,762,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • FCBC $2.34
  • MDXG $9.55
  • Revenue Next Year
  • FCBC $1.10
  • MDXG $11.43
  • P/E Ratio
  • FCBC $13.24
  • MDXG $33.87
  • Revenue Growth
  • FCBC N/A
  • MDXG 6.85
  • 52 Week Low
  • FCBC $33.88
  • MDXG $5.47
  • 52 Week High
  • FCBC $49.02
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • FCBC 39.47
  • MDXG 55.59
  • Support Level
  • FCBC $34.83
  • MDXG $7.06
  • Resistance Level
  • FCBC $37.39
  • MDXG $7.45
  • Average True Range (ATR)
  • FCBC 1.00
  • MDXG 0.32
  • MACD
  • FCBC 0.03
  • MDXG 0.00
  • Stochastic Oscillator
  • FCBC 30.20
  • MDXG 42.11

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: